Plain-English translation of NCT06835907 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is investigating whether baclofen, a medication already used to treat alcohol use disorder, works differently for people who also struggle with anxiety. Researchers want to understand if the medication helps people stay sober and reduces anxiety symptoms, and whether the benefits differ based on how much anxiety someone experiences.
Many people fighting alcohol addiction also deal with anxiety, but doctors don't yet fully understand how well this medication works for both problems together. This study aims to fill that gap so treatment can be better tailored to patients' needs.
You likely qualify if…
You likely don't qualify if…
If you join, you'll continue taking the medication as part of your regular care — the study itself doesn't add a new drug. Instead, over six weeks, you'll complete several questionnaires that ask about your drinking, anxiety levels, cravings, and how you're feeling. The researchers use your answers to see how well the treatment is working for you.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
Belgium
Universitair Ziekenhuis Brussel
Enrollment target
~58 participants
Started
October 2024
Primary completion
December 2029
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Cleo L Crunelle
Universitair Ziekenhuis Brussel
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.